rs779888892

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3PP5

The NM_177924.5(ASAH1):​c.124A>G​(p.Thr42Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000752 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T42M) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

ASAH1
NM_177924.5 missense, splice_region

Scores

9
9
Splicing: ADA: 0.9991
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2

Conservation

PhyloP100: 3.61
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr8-18075541-G-A is described in Lovd as [Likely_pathogenic].
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 8-18075542-T-C is Pathogenic according to our data. Variant chr8-18075542-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 560955.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}. Variant chr8-18075542-T-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASAH1NM_177924.5 linkc.124A>G p.Thr42Ala missense_variant, splice_region_variant Exon 2 of 14 ENST00000637790.2 NP_808592.2 Q13510-1Q53H01A8K0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASAH1ENST00000637790.2 linkc.124A>G p.Thr42Ala missense_variant, splice_region_variant Exon 2 of 14 1 NM_177924.5 ENSP00000490272.1 Q13510-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000159
AC:
4
AN:
251460
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135898
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000752
AC:
11
AN:
1461836
Hom.:
0
Cov.:
30
AF XY:
0.00000963
AC XY:
7
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000111
Hom.:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Spinal muscular atrophy-progressive myoclonic epilepsy syndrome Uncertain:2
-
Neuberg Centre For Genomic Medicine, NCGM
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The missense variant in c.124A>G in ASAH1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Thr42Ala variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.002% in gnomAD database. This variant has been reported to the ClinVar database as Uncertain Significance. The amino acid change p.Thr42Ala in ASAH1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Thr at position 42 is changed to a Ala changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Uncertain Significance (VUS). -

Sep 01, 2017
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Another missense mutation at the same amino acid (with a different substitution) has been described as disease-causing. Likely pathogenicity based on finding it in trans with another missense mutation in a 14-year-old female with progressive cognitive impairment, flaccid proximal limb weakness with childhood onset, hyperreflexia, seizure disorder, dystonia, myoclonus, mild cerebral atrophy. -

not provided Pathogenic:1
Oct 10, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 42 of the ASAH1 protein (p.Thr42Ala). This variant is present in population databases (rs779888892, gnomAD 0.01%). This missense change has been observed in individual(s) with spinal muscular atrophy (PMID: 27026573, 28733637, 34240417). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 560955). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Benign
-0.13
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T;T;T;.;T;T;T;T;T;.;.;.;.;T;T;T;T;T;.;T;T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.94
.;D;D;D;D;D;D;D;D;D;D;D;T;D;D;T;D;D;D;D;D
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.37
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.20
D
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-2.1
.;N;N;N;.;.;.;.;.;.;.;.;N;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.32
Sift
Benign
0.33
.;T;T;T;.;.;.;.;.;.;.;.;D;.;.;.;.;.;.;.;.
Sift4G
Benign
0.56
.;T;T;T;.;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.
Polyphen
0.20
B;B;P;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.59, 0.57, 0.57, 0.64
MutPred
0.24
Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);.;.;Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);.;.;Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);Loss of phosphorylation at T42 (P = 0.0137);.;.;.;
MVP
0.89
MPC
0.0088
ClinPred
0.97
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.52
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.98
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs779888892; hg19: chr8-17933051; API